SEC Filing Summary: Community Health Systems, Inc. (CYH)
Business Context and Reporting Period
This Form 8-K Current Report, dated February 2, 2026, discloses a material asset disposition completed on February 1, 2026. Community Health Systems, Inc. (the "Company") sold its ownership interest in specific joint ventures to Vanderbilt University Medical Center and its subsidiaries.
Key Financial Metrics and Transaction Details
- Transaction Type: Significant disposition of assets (Item 2.01).
- Assets Sold: 80% ownership interest in Clarksville Health System, G.P., and Clarksville Physician Services, G.P. (collectively, the "Joint Ventures"), which operate Tennova Healthcare - Clarksville in Tennessee.
- Purchase Price: $623 million in cash (subject to post-closing working capital adjustments).
- Additional Cash Distribution: Approximately $23 million in cash distributed to the Purchaser for amounts owed to the Joint Ventures by the Company.
- Financial Statements: Unaudited pro forma financial information for the nine months ended September 30, 2025, and the year ended December 31, 2024, is included as Exhibit 99.1.
Material Changes
The Company completed the sale of a significant portion of its operations in Clarksville, Tennessee. Prior to this transaction, the Purchaser held a minority interest in the Joint Ventures; this transaction transferred the remaining 80% interest to the Purchaser. The filing does not provide specific comparative revenue, profit, or debt metrics for the Company's remaining operations, as the focus is on the transaction mechanics and pro forma adjustments.
Guidance, Outlook, and Risks
The filing does not contain updated forward-looking guidance or management commentary regarding future operational outlook beyond the completion of this specific transaction. The document includes standard legal disclaimers noting that representations and warranties in the Purchase Agreement are subject to confidential disclosure schedules and contractual risk allocation mechanisms that may differ from an investor's view of materiality.
Investor Verification Checklist
- Review Exhibit 99.1 for the Unaudited Pro Forma Condensed Consolidated Financial Statements to understand the impact of the disposition on the Company's balance sheet and income statement.
- Verify the final purchase price after the post-closing working capital adjustment is finalized.
- Examine the Purchase Agreement (Exhibit 2.1) for any retained liabilities or contingent obligations related to the sold assets.
- Confirm the status of the $23 million distribution regarding amounts owed to the Joint Ventures.